Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
0.8%
1w
3.4%
1m
4.7%
3m
0.3%
6m
19.2%
1y
0.2%
5y
29.2%
10y
30.5%
all
20.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 217 0.8%
211
259
Company Overview

Sales
294 Cr
Growth: 8.0%
Profit after Tax
45.5 Cr
Growth: 5.6%
Small Cap
569 Cr
P/E: 32.4x
Industry P/E: 32.5x
Fundamentals

Sales (Cr) ₹ 294
Growth 8.0%
EBITDA 20.8%
P/S 4.9x
Dividend 1.0%
P/E 32.4x
Book Value ₹ 43.8
PEG Ratio 4.1x
ROE 16.5%
P/B 5.0x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (24)
Followers (1)